Back to Search Start Over

A Novel STAT1 Mutation Associated with Disseminated Mycobacterial Disease.

Authors :
Sampaio, Elizabeth
Bax, Hannelore
Hsu, Amy
Kristosturyan, Ervand
Pechacek, Joseph
Chandrasekaran, Prabha
Paulson, Michelle
Dias, Dalton
Spalding, Christine
Uzel, Gulbu
Ding, Li
McFarland, Elizabeth
Holland, Steven
Source :
Journal of Clinical Immunology. Aug2012, Vol. 32 Issue 4, p681-689. 9p.
Publication Year :
2012

Abstract

STAT1 is a key component of Interferon (IFN)-γ and IFN-α signaling and mediates protection against mycobacteria, fungal, viral infections, and cancer. Dominant negative inhibitory as well as gain of function heterozygous STAT1 mutations demonstrate that IFN-γ driven cellular responses need to be tightly regulated to control infections. We describe an autosomal dominant mutation in the SH2 domain of STAT1 that disrupts protein phosphorylation, c.1961T>A (M654K). The mutant allele does not permit STAT1 phosphorylation, and impairs STAT1 phosphorylation of the wild type allele. Protein dimerization is preserved but DNA binding activity, IFN-γ driven GAS-luciferase activity, and expression of IFN-γ target genes are reduced. IFN-α driven ISRE response, but not IFN-α driven GAS response, are preserved when cells are co-transfected with wild type and the mutant STAT1 constructs. M654K exerts a dominant negative effect on IFN-γ related immunity and is recessive for IFN-α induced immune function. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
02719142
Volume :
32
Issue :
4
Database :
Academic Search Index
Journal :
Journal of Clinical Immunology
Publication Type :
Academic Journal
Accession number :
77493471
Full Text :
https://doi.org/10.1007/s10875-012-9659-2